Academic Career Development in Pediatric Diabetes(K12)

描述(由申请人提供)： 这是对RFA-DK-02-024的一项新申请，该申请要求在匹兹堡大学匹兹堡儿童医院(CHP)建立一项由NIH支持的儿科糖尿病初级教师职业发展计划，以补充T32奖学金培训申请。随着我们进入一个基本科学能力和翻译探索的新时代，越来越少的报销和对临床创收的需求增加，使得年轻教师越来越难以开始学术生涯。因此，该计划的目的是培养下一代临床医生-科学家，在儿科糖尿病领域从事独立的学术生涯，强调基础科学进步的临床应用。 该计划的核心组成部分是：1)在学术上取得成功的导师的指导下进行学徒制；2)根据特定的研究和教育需求，为每个初级教员量身定做高级课程和教学研究；3)接触广泛的跨学科糖尿病研究研讨会；4)发展核心研究和学术生存技能；5)密切跟踪和指导教员的进步；以及6)向独立的学术生涯发展。培训计划的组织结构包括：1)计划主任席尔瓦·阿尔斯兰尼医学博士，他是儿科普通临床研究中心的主任；2)计划联合主任Massimo Trucco M.D.，他是保健中心和大学JDRF中心补助金的主任；3)咨询委员会，由五个不同的糖尿病研究轨道的副主任组成；4)初级教员委员会，为每个K12被任命的人量身定做；以及5)一个外部顾问委员会，由3名高水平的糖尿病研究人员组成。从一批有前途的年轻教员中，无论是在T32项目的毕业生中还是在没有CHP的情况下，每年都将有两名教师获得资助。任命将在咨询委员会仔细审查和推荐后作出。特别考虑从少数民族人口中招聘和留住初级教员。获奖者将在1-2年的时间里将80%的时间用于研究。计划中的K12计划将能够吸引、发展和留住糖尿病儿科科学家，他们将在独立资金方面具有竞争力，并最终将为下一代年轻研究人员形成一批高级教师导师。

DESCRIPTION (provided by applicant): This is a new application in response to RFA-DK-02-024 for the establishment of a NIH-supported junior faculty career development program in pediatric diabetes at the Children's Hospital of Pittsburgh (CHP), University of Pittsburgh, to complement the T32 Fellowship Training application. As we usher in a new era of basic scientific capabilities and translational exploration, decreasing reimbursement and increased demands for clinical revenue generation have made it increasingly difficult for young faculty to "jump-start" an academic career. Therefore, the aim of this program is to train the next generation of clinician-scientists for independent academic careers in pediatric diabetes emphasizing the clinical application of basic science advances. The core components of this program are: 1) apprenticeship with an academically successful mentor; 2) individually tailored ADVANCED course work and didactic study for each junior faculty based upon specific research and educational needs; 3) exposure to a broad range of interdisciplinary diabetes research seminars; 4) development of core research and ACADEMIC SURVIVAL SKILLS; 5) close follow up and guidance of faculty progress; and 6) evolution towards an INDEPENDENT academic career. The organizational structure of the training program includes: 1) the Program Director, Silva Arslanian M.D., who is the Director of the pediatric General Clinical Research Center; 2) the Program Co-Director, Massimo Trucco M.D., who is the Director of the JDRF Center Grant at CHP and the University; 3) the ADVISORY committee, comprised of the Associate Directors of five different research tracks in diabetes; 4) the Junior Faculty Committee, custom designed for each K12 appointee; and 5) An External Advisory Board of 3 highly accomplished diabetes researchers. From a pool of promising young faculty, from within (graduates of the T32 program) or without the CHP, two will be funded each year. Appointment will be made after careful scrutiny, and recommendation by the Advisory Committee. Special consideration is given to recruiting and retaining junior faculty from minority populations. Awardees will spend 80% of their time in research over a 1-2 year period. The planned K12 program will enable the attraction, development, and retention of pediatric scientists in diabetes who will be competitive for independent funding and will eventually form a group of senior faculty mentors for the future generation of young investigators.